Company intelligence / Profile preview

GRY-Pharma

Kirchzarten, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

GRY-Pharma is a German pharmaceutical company that specializes in the development and distribution of generic medicinal products. Based in Kirchzarten, the company focuses on providing cost-effective therapeutic options across several key areas, including pain management, cardiovascular health, and respiratory diseases. As a subsidiary of the Teva Group, GRY-Pharma leverages extensive manufacturing and distribution networks to supply the German healthcare market. Their portfolio includes a wide range of prescription and over-the-counter medications designed to improve patient access to essential treatments.

Therapeutic areas: CardiovascularImmunologyNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on GRY-Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRY-Pharma.

Explore the full profile